Akers Biosciences Inc (NASDAQ:AKER) fell 29.5% during mid-day trading on Thursday . The stock traded as low as $1.50 and last traded at $1.60. 1,116,557 shares were traded during mid-day trading, an increase of 3% from the average session volume of 1,080,066 shares. The stock had previously closed at $2.27.
Akers Biosciences (NASDAQ:AKER) last posted its quarterly earnings data on Tuesday, August 14th. The medical instruments supplier reported ($0.02) earnings per share (EPS) for the quarter. The firm had revenue of $0.53 million during the quarter. Akers Biosciences had a negative net margin of 266.60% and a negative return on equity of 97.10%.
Several hedge funds have recently bought and sold shares of the stock. BlackRock Inc. grew its stake in Akers Biosciences by 8,438.7% during the 2nd quarter. BlackRock Inc. now owns 1,315,815 shares of the medical instruments supplier’s stock worth $509,000 after purchasing an additional 1,300,405 shares in the last quarter. Candriam Luxembourg S.C.A. acquired a new position in Akers Biosciences during the 3rd quarter worth $348,000. Finally, Northern Trust Corp acquired a new position in Akers Biosciences during the 1st quarter worth $128,000. Hedge funds and other institutional investors own 7.64% of the company’s stock.
TRADEMARK VIOLATION NOTICE: This story was first published by Week Herald and is the property of of Week Herald. If you are accessing this story on another publication, it was stolen and reposted in violation of international copyright & trademark laws. The correct version of this story can be viewed at https://weekherald.com/2018/11/16/akers-biosciences-aker-trading-down-29-5.html.
Akers Biosciences, Inc, together with its subsidiaries, develops, manufactures, and supplies rapid screening and testing products designed to deliver healthcare information to healthcare providers and consumers in the United States, the People's Republic of China, and internationally. The company's marketed products include BreathScan, a disposable breath alcohol detector; BreathScan PRO, a quantitative breath alcohol detection system; METRON, a disposable breath ketone device to monitor ketosis; and BreathScan Lync, a non-invasive, quantitative measurement of biological markers for health and wellness.
Receive News & Ratings for Akers Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Akers Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.